Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The effects of psychosocial services in substance abuse treatment.

McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP.

JAMA. 1993 Apr 21;269(15):1953-9.

PMID:
8385230
2.
3.

Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost.

Avants SK, Margolin A, Sindelar JL, Rounsaville BJ, Schottenfeld R, Stine S, Cooney NL, Rosenheck RA, Li SH, Kosten TR.

Am J Psychiatry. 1999 Jan;156(1):27-33.

PMID:
9892294
4.

Are supplementary services provided during methadone maintenance really cost-effective?

Kraft MK, Rothbard AB, Hadley TR, McLellan AT, Asch DA.

Am J Psychiatry. 1997 Sep;154(9):1214-9.

PMID:
9286179
5.

Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.

Sees KL, Delucchi KL, Masson C, Rosen A, Clark HW, Robillard H, Banys P, Hall SM.

JAMA. 2000 Mar 8;283(10):1303-10.

PMID:
10714729
6.

Contingency management of urinalysis results and intensity of counseling services have an interactive impact on methadone maintenance treatment outcome.

Calsyn DA, Wells EA, Saxon AJ, Jackson TR, Wrede AF, Stanton V, Fleming C.

J Addict Dis. 1994;13(3):47-63.

PMID:
7734459
7.

Different components of opioid-substitution treatment predict outcomes of patients with and without a parent with substance-use problems.

Trafton JA, Tracy SW, Oliva EM, Humphreys K.

J Stud Alcohol Drugs. 2007 Mar;68(2):165-72.

PMID:
17286334
8.

Methadone maintenance in primary care: a randomized controlled trial.

Fiellin DA, O'Connor PG, Chawarski M, Pakes JP, Pantalon MV, Schottenfeld RS.

JAMA. 2001 Oct 10;286(14):1724-31.

PMID:
11594897
9.

Psychotherapy in community methadone programs: a validation study.

Woody GE, McLellan AT, Luborsky L, O'Brien CP.

Am J Psychiatry. 1995 Sep;152(9):1302-8.

PMID:
7653685
10.

Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients.

Backmund M, Meyer K, Eichenlaub D, Sch├╝tz CG.

Drug Alcohol Depend. 2001 Oct 1;64(2):173-80.

PMID:
11543987
11.

Rationale for maintenance pharmacotherapy of opiate dependence.

Kreek MJ.

Res Publ Assoc Res Nerv Ment Dis. 1992;70:205-30. Review.

PMID:
1346939
12.

Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.

Strain EC, Stitzer ML, Liebson IA, Bigelow GE.

J Clin Psychopharmacol. 1996 Feb;16(1):58-67.

PMID:
8834420
13.

Managing psychiatric comorbidity within versus outside of methadone treatment settings: a randomized and controlled evaluation.

Brooner RK, Kidorf MS, King VL, Peirce J, Neufeld K, Stoller K, Kolodner K.

Addiction. 2013 Nov;108(11):1942-51. doi: 10.1111/add.12269. Epub 2013 Jul 19.

14.

A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model.

King VL, Kidorf MS, Stoller KB, Schwartz R, Kolodner K, Brooner RK.

J Subst Abuse Treat. 2006 Dec;31(4):385-93. Epub 2006 Aug 14.

PMID:
17084792
15.

Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.

Peirce JM, Petry NM, Stitzer ML, Blaine J, Kellogg S, Satterfield F, Schwartz M, Krasnansky J, Pencer E, Silva-Vazquez L, Kirby KC, Royer-Malvestuto C, Roll JM, Cohen A, Copersino ML, Kolodner K, Li R.

Arch Gen Psychiatry. 2006 Feb;63(2):201-8.

PMID:
16461864
16.
17.

Outcomes of an AIDS prevention program for methadone patients.

Magura S, Siddiqi Q, Shapiro J, Grossman JI, Lipton DS, Marion IJ, Weisenfeld L, Amann KR, Koger J.

Int J Addict. 1991 Jun;26(6):629-55.

PMID:
1757169
18.

Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.

Schottenfeld RS, Chawarski MC, Pakes JR, Pantalon MV, Carroll KM, Kosten TR.

Am J Psychiatry. 2005 Feb;162(2):340-9.

PMID:
15677600
19.

Factors affecting the outcome of methadone maintenance treatment in opiate dependence.

Kamal F, Flavin S, Campbell F, Behan C, Fagan J, Smyth R.

Ir Med J. 2007 Mar;100(3):393-7.

PMID:
17491538
20.

Using enhanced and integrated services to improve response to standard methadone treatment: changing the clinical infrastructure of treatment networks.

Neufeld K, Kidorf M, King V, Stoller K, Clark M, Peirce J, Brooner RK.

J Subst Abuse Treat. 2010 Mar;38(2):170-7. doi: 10.1016/j.jsat.2009.07.003. Epub 2009 Aug 29.

Supplemental Content

Support Center